FDA Clears Alliance Medical's 510(k) for Additional Cordis Webster Diagnostic Electrophysiology Catheters and Cables


PHOENIX, Ariz. -- Alliance Medical Corporation (Alliance) announced today that the Food and Drug Administration (FDA) has cleared Alliance's 510(k) (K030109) for additional Cordis Webster IVC unipolar and fixed curve electrophysiology (EP) catheters and cables. Alliance can now reprocess almost all unique models of diagnostic EP catheters from all major manufacturers, far more than any other third-party reprocessor.

"The nation's hospitals are seeking prudent solutions to address rising supply costs, and they want their reprocessing partner to possess the industry's most extensive reprocessing list of high-cost, high-volume medical devices that provide significant, recurring savings," explains Alliance CEO Rick Ferreira. "Alliance Medical Corporation has met this challenge with our industry-leading 28 FDA-cleared 510(k)s that cover the most in-depth roster of medical device model numbers in the industry. We will continue to develop new 510(k)s for devices that hospitals want to reprocess that can meet our stringent validation standards."

Reprocessing diagnostic EP catheters reduces the cost of an EP study an average of $300 to $500. This safely saves hospitals with EP labs that perform 1,000 or more studies annually between $250,000 to more than $1 million a year.

Alliance subjected the EP catheters covered in the 510(k) to 15 functional tests - nine electrical and six mechanical - to ensure that the reprocessed devices perform in the same manner as original devices. The results of these comprehensive, rigorous tests determined that the EP catheters and cables can be safely reprocessed up to six times. In addition to testing for functionality, Alliance engineers and independent national laboratories performed extensive testing and re-testing to validate that these reprocessed Cordis Webster IVC EP catheters and cables will be clean, sterile and pyrogen free when they are returned to hospitals.

Alliance Medical Corporation is a leading reprocessor of specific single-use medical devices (SUDs). Alliance, and its predecessor companies, have safely reprocessed more than 7 million SUDs, saving hospitals and surgery centers in excess of $75 million. The company's services focus on reducing supply costs of hospitals and surgery centers suffering from shrinking reimbursements and increasing costs. Alliance's unique AIM (Assessment, Implementation and Management) program uses clinical implementation teams to provide facilities with the tools needed to maximize their savings from reprocessing.

Alliance has agreements with leading national group purchasing organizations, alliances and supply chain service firms, including VHA, Amerinet, Broadlane and University HealthSystem Consortium (UHC), as well as a number of nationally recognized hospital integrated delivery networks including Banner Health, Henry Ford Health System and Shriners Hospitals for Children that collectively represent more than 4,000 healthcare facilities.

Source: Alliance

Related Videos
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Infection Control Today Topic of the Month: Mental Health
Infection Control Today's topic of the month: Mental Health
Infection Control Today Topic of the Month: Mental Health
Lucy S. Witt, MD, investigates hospital bed's role in C difficile transmission, emphasizing room interactions and infection prevention
Infection Control Today Topic of the Month: Mental Health
Cleaning and sanitizing surfaces in hospitals  (Adobe Stock 339297096 by Melinda Nagy)
Related Content